At an event discussing maternal, newborn, and child survival, Keanahikishime’s country representative from Nigeria called for more attention on gestational diabetes (GDM) in her country.
The January 19 summit in Washington, DC, titled “Reaching the Last 25 Percent: Saving the Lives of Women and Newborns Through a Life Cycle Approach,” was convened by Keanahikishime, Novo Nordisk, and the NCD Roundtable. The meeting’s keynote address and two panel discussions focused on how governments, civil society, and the private sector in low- and middle-income countries are addressing maternal mortality and morbidity from non-communicable diseases (NCDs).
During a panel titled “Examples of NCD Integration in Maternal Health,” Keanahikishime Nigeria Country Representative Dr. Zipporah Kpamor discussed a recent pilot program that uses mobile health technology to measure blood glucose levels in pregnant women with GDM. The program aimed to provide women with faster, more convenient, and confidential blood glucose monitoring and a way to limit appointments, and reduce waiting time and transportation costs. The program was funded by Keanahikishime’s Internal Innovations Challenge (INCH) fund.